These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10537927)

  • 21. Conservatism versus radicalism in the diagnosis of cervical cancer.
    Ahronheim JH
    Mich Med; 1974 May; 73(14):261 passim. PubMed ID: 4825306
    [No Abstract]   [Full Text] [Related]  

  • 22. False negative cervical cytology.
    Evans H
    Pa Med; 1989 Mar; 92(3):62-3. PubMed ID: 2927953
    [No Abstract]   [Full Text] [Related]  

  • 23. Invasive adenocarcinoma of the cervix following Lletz for adenocarcinoma in situ.
    Townsend DE
    Gynecol Oncol; 1996 Feb; 60(2):332. PubMed ID: 8631562
    [No Abstract]   [Full Text] [Related]  

  • 24. [The occurrence of cervix uteri cancer in young women].
    Crane-Elders AB; Bouma J
    Ned Tijdschr Geneeskd; 1982 Nov; 126(46):2096-9. PubMed ID: 7177215
    [No Abstract]   [Full Text] [Related]  

  • 25. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carcinoma in situ and cervical carcinoma during the use of oral contraceptives].
    Wunder G
    Fortschr Med; 1973 Sep; 91(27):1082-4. PubMed ID: 4746761
    [No Abstract]   [Full Text] [Related]  

  • 27. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caring for the patient with cancer of the cervix. Part 1.
    Fitzpatrick G
    Nurs Care; 1976 Oct; 9(10):17-22. PubMed ID: 1049865
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA content and chromatin pattern analysis on cervical carcinoma in situ.
    Sprenger E; Moore GW; Naujoks H; Schlüter G; Sandritter W
    Acta Cytol; 1973; 17(1):27-31. PubMed ID: 4119230
    [No Abstract]   [Full Text] [Related]  

  • 30. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electronic analysis of colposcopic and cytologic findings in carcinoma in situ].
    Szalmay G; Roemer VM; Jochum L
    Arch Gynakol; 1975 Nov; 219(1-4):68-9. PubMed ID: 1243514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Carcinoma in situ of the uterine cervix in our conization material].
    Krivos V; Hronec M; Valásek F
    Bratisl Lek Listy; 1988 Mar; 89(3):185-9. PubMed ID: 3390724
    [No Abstract]   [Full Text] [Related]  

  • 33. [Position of cervix cancer detection in Gabon over a period of 19 years].
    Meye JF; Mabika B; Belembaogo E; Engongah-Beka T; Minko-Mi Etoua D
    Ann Pathol; 2001 Jun; 21(3):233-6. PubMed ID: 11468560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased detection of clue cells in smears from cervical intraepithelial lesions with reduced expression of COX-2.
    Figueiredo PG; Sarian LO; Tambascia JK; Simões JA; Rabelo-Santos SH; Discacciati MG; Derchain S
    Diagn Cytopathol; 2008 Oct; 36(10):705-9. PubMed ID: 18773440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical carcinoma in Georgia.
    Johnston GS; Wilson-Bell N
    J Med Assoc Ga; 1981 Nov; 70(11):805-6. PubMed ID: 7334290
    [No Abstract]   [Full Text] [Related]  

  • 38. The minimally abnormal Pap smear. A conservative approach.
    Zuber TJ
    Am Fam Physician; 1996 Mar; 53(4):1042, 1048, 1050 passim. PubMed ID: 8629553
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation and management of the AGUS Papanicolaou smear.
    Kaferle JE; Malouin JM
    Am Fam Physician; 2001 Jun; 63(11):2239-44. PubMed ID: 11417776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of endocervical curettage in the screening for cervical cancer: apropos of a series of 31 cases].
    Ayoubi JM; Cayrol MH; Meddoun M; Benevent JB; Degoy J; Pons JC
    Gynecol Obstet Fertil; 2000 Jun; 28(6):455-9. PubMed ID: 10935311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.